Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient

Ann Hematol. 2003 Jul;82(7):452-4. doi: 10.1007/s00277-003-0667-4. Epub 2003 May 15.

Abstract

Pyomyositis is a rare complication of chemotherapy. A 35-year-old male patient with myelodysplastic syndrome developed Stenotrophomonas maltophilia bacteremia shortly after chemotherapy, and Stenotrophomonas maltophilia-related pyomyositis was encountered after recovery from neutropenia. He recovered completely after surgical drainage and a protracted course of antibiotic treatment. It is postulated that subclinical myopathy, immunosuppression secondary to the malignancy, or chemotherapeutic drugs may predispose to pyomyositis. Early recognition of this unusual complication in a cancer patient undergoing chemotherapy can prevent further catastrophes.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Diagnosis, Differential
  • Humans
  • Leg / pathology
  • Magnetic Resonance Imaging
  • Male
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / drug therapy
  • Myositis / chemically induced*
  • Myositis / diagnosis
  • Myositis / therapy
  • Opportunistic Infections
  • Sepsis / chemically induced*
  • Sepsis / diagnosis
  • Sepsis / therapy
  • Stenotrophomonas maltophilia*

Substances

  • Antineoplastic Agents